Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

Recombinant Human Porphobilinogen Deaminase

EU orphan designation number: EU/3/02/103   
Active ingredient: Recombinant Human Porphobilinogen Deaminase
Indication: Treatment of acute intermittent porphyria
Sponsor: Chiesi Farmaceutici S.p.A.
Via Palermo 26/A, 43122 Parma, Italia

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/06/2002 Orphan designation EMEA/OD/083/01 (2002)2231 of 12/06/2002
4/02/2005 Change of name and/or address of sponsor
27/07/2018 Transfer of orphan designation EMEA/OD/083/01/T/01 (2018)5048 of 25/07/2018